Sepelvaltimotautikohtaus, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Yiu KH, Mok MY, Wang S, ym. Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2012;30(3):345-50 «PMID: 22409930»PubMed
2. Romero-Díaz J, Vargas-Vóracková F, Kimura-Hayama E, ym. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) 2012;51(1):110-9 «PMID: 22039268»PubMed
3. Ungprasert P, Charoenpong P, Ratanasrimetha P, ym. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 2014;33(8):1099-104 «PMID: 24859783»PubMed
4. Nikus KC, Eskola MJ, Virtanen VK, ym. ST-depression with negative T waves in leads V4-V5--a marker of severe coronary artery disease in non-ST elevation acute coronary syndrome: a prospective study of Angina at rest, with troponin, clinical, electrocardiographic, and angiographic correlation. Ann Noninvasive Electrocardiol 2004;9(3):207-14 «PMID: 15245335»PubMed
5. Sclarovsky S, Rechavia E, Strasberg B, ym. Unstable angina: ST segment depression with positive versus negative T wave deflections--clinical course, ECG evolution, and angiographic correlation. Am Heart J 1988;116(4):933-41 «PMID: 3177193»PubMed
6. Nikus K, Järvinen O, Sclarovsky S, ym. Electrocardiographic presentation of left main disease in patients undergoing urgent or emergent coronary artery bypass grafting. Postgrad Med 2011;123(2):42-8 «PMID: 21474892»PubMed
7. Nikus KC, Sclarovsky S, Huhtala H, ym. Electrocardiographic presentation of global ischemia in acute coronary syndrome predicts poor outcome. Ann Med 2012;44(5):494-502 «PMID: 21679105»PubMed
8. Nikus K. 12-lead Electrocardiogram in Acute Coronary Syndrome: Association with Coronary Angiography Findings and Outcome. Acta Universitatis Tamperensis; 1776, Tampere University Press, Tampere 2012
9. . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343(8893):311-22 «PMID: 7905143»PubMed
10. Kontos MC, McQueen RH, Jesse RL, ym. Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 2001;37(5):431-8 «PMID: 11326177»PubMed
11. Chang AM, Shofer FS, Tabas JA, ym. Lack of association between left bundle-branch block and acute myocardial infarction in symptomatic ED patients. Am J Emerg Med 2009;27(8):916-21 «PMID: 19857407»PubMed
12. Meyers HP, Limkakeng AT Jr, Jaffa EJ, ym. Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: A retrospective case-control study. Am Heart J 2015;170(6):1255-64 «PMID: 26678648»PubMed
13. Lindow T, Mokhtari A, Nyström A, ym. Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction. Int J Cardiol 2024;395():131569 «PMID: 37931659»PubMed
14. Dodd KW, Zvosec DL, Hart MA, ym. Electrocardiographic Diagnosis of Acute Coronary Occlusion Myocardial Infarction in Ventricular Paced Rhythm Using the Modified Sgarbossa Criteria. Ann Emerg Med 2021;78(4):517-529 «PMID: 34172301»PubMed
15. Haaf P, Drexler B, Reichlin T, ym. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012;126(1):31-40 «PMID: 22623715»PubMed
16. Biener M, Mueller M, Vafaie M, ym. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013;167(4):1134-40 «PMID: 23063209»PubMed
17. Bandstein N, Ljung R, Johansson M, ym. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014;63(23):2569-2578 «PMID: 24694529»PubMed
18. Sandoval Y, Smith SW, Love SA, ym. Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction. Am J Med 2017;130(9):1076-1083.e1 «PMID: 28344141»PubMed
19. Bularga A, Lee KK, Stewart S, ym. High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome. Circulation 2019;140(19):1557-1568 «PMID: 31475856»PubMed
20. Sandoval Y, Nowak R, deFilippi CR, ym. Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I. J Am Coll Cardiol 2019;74(3):271-282 «PMID: 31319909»PubMed
21. Neumann JT, Twerenbold R, Ojeda F, ym. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. N Engl J Med 2019;380(26):2529-2540 «PMID: 31242362»PubMed
22. Samad Z, Hakeem A, Mahmood SS, ym. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department. J Nucl Cardiol 2012;19(2):364-76 «PMID: 22322526»PubMed
23. Barbosa MF, Canan A, Xi Y, ym. Comparative Effectiveness of Coronary CT Angiography and Standard of Care for Evaluating Acute Chest Pain: A Living Systematic Review and Meta-Analysis. Radiol Cardiothorac Imaging 2023;5(4):e230022 «PMID: 37693194»PubMed
24. Gray AJ, Roobottom C, Smith JE, ym. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial. BMJ 2021;374():n2106 «PMID: 34588162»PubMed
25. Gray AJ, Roobottom C, Smith JE, ym. Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome: the RAPID-CTCA RCT. Health Technol Assess 2022;26(37):1-114 «PMID: 36062819»PubMed
26. Elgendy IY, Elgendy AY, Mahmoud AN, ym. Intravenous β-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol 2016;223():891-897 «PMID: 27584567»PubMed
27. Hoedemaker NP, Roolvink V, de Winter RJ, ym. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials. Eur Heart J Acute Cardiovasc Care 2020;9(5):469-477 «PMID: 30759994»PubMed
28. Yndigegn T, Lindahl B, Mars K, ym. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med 2024;390(15):1372-1381 «PMID: 38587241»PubMed
29. Silvain J, Cayla G, Ferrari E, ym. Beta-Blocker Interruption or Continuation after Myocardial Infarction. N Engl J Med 2024;391(14):1277-1286 «PMID: 39213187»PubMed
30. Andersen HR, Nielsen TT, Rasmussen K, ym. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349(8):733-42 «PMID: 12930925»PubMed
31. Busk M, Maeng M, Rasmussen K, ym. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 2008;29(10):1259-66 «PMID: 17956874»PubMed
32. Widimsky P, Bilkova D, Penicka M, ym. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. Eur Heart J 2007;28(6):679-84 «PMID: 17298968»PubMed
33. Nunn CM, O'Neill WW, Rothbaum D, ym. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol 1999;33(3):640-6 «PMID: 10080463»PubMed
34. Zijlstra F, Hoorntje JC, de Boer MJ, ym. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341(19):1413-9 «PMID: 10547403»PubMed
35. Bonnefoy E, Lapostolle F, Leizorovicz A, ym. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360(9336):825-9 «PMID: 12243916»PubMed
36. Bonnefoy E, Steg PG, Boutitie F, ym. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009;30(13):1598-606 «PMID: 19429632»PubMed
37. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13-20 «PMID: 12517460»PubMed
38. Svensson L, Aasa M, Dellborg M, ym. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J 2006;151(4):798.e1-7 «PMID: 16569536»PubMed
39. Aasa M, Dellborg M, Herlitz J, ym. Risk reduction for cardiac events after primary coronary intervention compared with thrombolysis for acute ST-elevation myocardial infarction (five-year results of the Swedish early decision reperfusion strategy [SWEDES] trial). Am J Cardiol 2010;106(12):1685-91 «PMID: 21126610»PubMed
40. Boersma E, Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27(7):779-88 «PMID: 16513663»PubMed
41. Pinto DS, Kirtane AJ, Nallamothu BK, ym. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006;114(19):2019-25 «PMID: 17075010»PubMed
42. Stenestrand U, Lindbäck J, Wallentin L, ym. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296(14):1749-56 «PMID: 17032988»PubMed
43. European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329(6):383-9 «PMID: 8326971»PubMed
44. Castaigne AD, Hervé C, Duval-Moulin AM, ym. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989;64(2):30A-33A; discussion 41A-42A «PMID: 2662741»PubMed
45. Schofer J, Büttner J, Geng G, ym. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990;66(20):1429-33 «PMID: 2251987»PubMed
46. . Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ 1992;305(6853):548-53 «PMID: 1393033»PubMed
47. Weaver WD, Cerqueira M, Hallstrom AP, ym. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270(10):1211-6 «PMID: 8355383»PubMed
48. Morrison LJ, Verbeek PR, McDonald AC, ym. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 2000;283(20):2686-92 «PMID: 10819952»PubMed
49. Stenestrand U, Lindbäck J, Wallentin L, ym. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296(14):1749-56 «PMID: 17032988»PubMed
50. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1997;30(5):1181-6 «PMID: 9350912»PubMed
51. . Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990;336(8719):827-30 «PMID: 1976875»PubMed
52. Lewis HD Jr, Davis JW, Archibald DG, ym. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309(7):396-403 «PMID: 6135989»PubMed
53. Cairns JA, Gent M, Singer J, ym. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985;313(22):1369-75 «PMID: 3903504»PubMed
54. Théroux P, Ouimet H, McCans J, ym. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319(17):1105-11 «PMID: 3050522»PubMed
55. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86 «PMID: 11786451»PubMed
56. Wallentin LC. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. J Am Coll Cardiol 1991;18(7):1587-93 «PMID: 1960301»PubMed
57. . Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308(6921):81-106 «PMID: 8298418»PubMed
58. Mehta SR, Tanguay JF, Eikelboom JW, ym. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376(9748):1233-43 «PMID: 20817281»PubMed
59. Montelescot G. Intravenous enoxaparin associated with better ischaemic outcomes in primary PCI for STEMI than unfractionated heparin: results from the ATOLL study. European Society of Cardiology 2010 Congress
60. Montalescot G, Ellis SG, de Belder MA, ym. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv 2010;3(2):203-12 «PMID: 20170878»PubMed
61. Brieger D, Collet JP, Silvain J, ym. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2011;77(2):182-90 «PMID: 20578166»PubMed
62. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR, ym. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354(14):1464-76 «PMID: 16537663»PubMed
63. Mehran R, Baber U, Sharma SK, ym. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med 2019;381(21):2032-2042 «PMID: 31556978»PubMed
64. Kim BK, Hong SJ, Cho YH, ym. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. JAMA 2020;323(23):2407-2416 «PMID: 32543684»PubMed
65. Ge Z, Kan J, Gao X, ym. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet 2024;403(10439):1866-1878 «PMID: 38599220»PubMed
66. Valgimigli M, Hong SJ, Gragnano F, ym. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. Lancet 2024;404(10456):937-948 «PMID: 39226909»PubMed
67. Laudani C, Giacoppo D, Occhipinti G, ym. Aspirin or P2Y(12) Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes. JACC Cardiovasc Interv 2025;18(15):1848-1859 «PMID: 40803759»PubMed
68. Kang J, Park KW, Lee H, ym. Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study. Circulation 2023;147(2):108-117 «PMID: 36342475»PubMed
69. Choi KH, Park YH, Lee JY, ym. Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. Lancet 2025;405(10486):1252-1263 «PMID: 40174599»PubMed
70. Valgimigli M, Choi KH, Giacoppo D, ym. Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. Lancet 2025;406(10508):1091-1102 «PMID: 40902613»PubMed
71. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338():b1665 «PMID: 19454737»PubMed
72. Lawes CM, Bennett DA, Feigin VL, ym. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35(3):776-85 «PMID: 14976329»PubMed
73. Psaty BM, Lumley T, Furberg CD, ym. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289(19):2534-44 «PMID: 12759325»PubMed
74. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981-97 «PMID: 12479763»PubMed
75. Pahor M, Psaty BM, Alderman MH, ym. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356(9246):1949-54 «PMID: 11130522»PubMed
76. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362(9395):1527-35 «PMID: 14615107»PubMed
77. Ettehad D, Emdin CA, Kiran A, ym. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387(10022):957-967 «PMID: 26724178»PubMed
78. Hoenig MR, Doust JA, Aroney CN, ym. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006;(3):CD004815 «PMID: 16856061»PubMed
79. Alexander KP, Newby LK, Cannon CP, ym. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007;115(19):2549-69 «PMID: 17502590»PubMed
80. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, ym. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28(13):1598-660 «PMID: 17569677»PubMed
81. Tegn N, Abdelnoor M, Aaberge L, ym. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016;387(10023):1057-1065 «PMID: 26794722»PubMed
82. Bach RG, Cannon CP, Weintraub WS, ym. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004;141(3):186-95 «PMID: 15289215»PubMed
83. Alexander KP, Newby LK, Bhapkar MV, ym. International variation in invasive care of the elderly with acute coronary syndromes. Eur Heart J 2006;27(13):1558-64 «PMID: 16760200»PubMed
84. Liistro F, Angioli P, Falsini G, ym. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart 2005;91(10):1284-8 «PMID: 15761051»PubMed
85. Mehta SR, Granger CB, Boden WE, ym. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360(21):2165-75 «PMID: 19458363»PubMed
86. Montalescot G, Cayla G, Collet JP, ym. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA 2009;302(9):947-54 «PMID: 19724041»PubMed
87. Thiele H, Rach J, Klein N, ym. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 2012;33(16):2035-43 «PMID: 22108830»PubMed
88. Buber J, Goldenberg I, Kimron L, ym. One-year outcome following coronary angiography in elderly patients with non-ST elevation myocardial infarction: real-world data from the Acute Coronary Syndromes Israeli Survey (ACSIS). Coron Artery Dis 2013;24(2):102-9 «PMID: 23242010»PubMed
89. Lopes RD, Subherwal S, Holmes DN, ym. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 2012;33(16):2044-53 «PMID: 22396323»PubMed
90. Narins CR. Treatment of coronary disease in elderly individuals. Cardiol J 2007;14(2):109-12 «PMID: 18651445»PubMed
91. Abdelnoor M, Andersen JG, Arnesen H, ym. Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost. Vasc Health Risk Manag 2017;13():101-109 «PMID: 28356750»PubMed
92. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290(1):86-97 «PMID: 12837716»PubMed
93. Chow CK, Jolly S, Rao-Melacini P, ym. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121(6):750-8 «PMID: 20124123»PubMed
94. Snaterse M, Dobber J, Jepma P, ym. Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis. Heart 2016;102(1):50-6 «PMID: 26567234»PubMed
95. Dibben G, Faulkner J, Oldridge N, ym. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2021;11(11):CD001800 «PMID: 34741536»PubMed
96. Dibben GO, Faulkner J, Oldridge N, ym. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J 2023;44(6):452-469 «PMID: 36746187»PubMed
97. Tonet E, Raisi A, Zagnoni S, ym. Multidomain Rehabilitation for Older Patients with Myocardial Infarction. N Engl J Med 2025;393(10):973-982 «PMID: 40879431»PubMed
98. Gonçalves C, Raimundo A, Abreu A, ym. Exercise Intensity in Patients with Cardiovascular Diseases: Systematic Review with Meta-Analysis. Int J Environ Res Public Health 2021;18(7): «PMID: 33808248»PubMed